切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2008, Vol. 04 ›› Issue (05) : 443 -450. doi: 10.3877/cma.j.issn.1673-5250.2008.05.110

论著

子宫内膜异位症患者凋亡相关基因的研究
马俊旗, 丁岩   
  1. 新疆医科大学第一附属医院妇科(新疆,830054)
  • 出版日期:2008-10-01

To Evaluate the Apoptosis Gene in Relation to Endometriosis

Jun-qi MA, Yan DING   

  1. Department of Gynecology, the First Affiliated Hospital of Xinjiang Medical University, Xinjiang 830054, China
  • Published:2008-10-01
引用本文:

马俊旗, 丁岩. 子宫内膜异位症患者凋亡相关基因的研究[J]. 中华妇幼临床医学杂志(电子版), 2008, 04(05): 443-450.

Jun-qi MA, Yan DING. To Evaluate the Apoptosis Gene in Relation to Endometriosis[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2008, 04(05): 443-450.

目的

通过对临床子宫内膜异位症(endometriosis, EMS)患者异位内膜及在位内膜survivin mRNA,bcl-2 mRNA及cox-2 mRNA表达的测定,探讨SurvivinBcl-2及Cox-2在子宫内膜异位症发病及发展中的分子生物学机制及其三者的相关性。

方法

选取2006年1月至2006年11月,在新疆医科大学第一附属医院妇科接受开腹手术或腹腔镜手术治疗的子宫内膜异位症患者32例为研究对象(EMS组),并在术中取得异位内膜组织、在位内膜组织,另取正常妇女(除外激素依赖性疾病或激素治疗患者)正常子宫内膜32例(对照组)(分组征得患者本人的知情同意),应用半定量逆转录-聚合酶链反应(RT-PCR)方法,测定survivin,bcl-2及cox-2的mRNA表达水平。

结果

与对照组相比,EMS组患者异位内膜的survivin mRNA,bcl-2 mRNA的表达水平上调,cox-2 mRNA的表达水平也明显上调,且总体survivin,bcl-2及cox-2的mRNA表达与子宫内膜异位症呈正相关,三者有明显相关性。而EMS组在位内膜与之相比,Survivin上调,Bcl-2,Cox-2变化差异无显著意义。

结论

子宫内膜异位症患者SurvivinBcl-2及Cox-2上调,可能是子宫内膜异位症发生发展的分子生物学机制之一,与异位内膜的发生和种植有关,且三类基因在疾病的发展中关系密切。

Objective

To evaluate the molecular mechanism by measuring the gene expression of Survivin, Bcl-2 and Cox-2 in patients with endometriosis(EMS) and investigate their effects on the initiation and maintenance of endometriosis.

Methods

From January 2006 to November 2006, the ectopic endometrium and eutopic endometrium were obtained from 32 patients with endometriosis (EMS group) and from 32 normal endometrium(the control group). Informed consent was obtained from all patients. The mRNA expression of survivin, bcl-2 and cox-2 were measured by semi-quantitative reverse transcription-polymerase chain reaction(RT-PCR).

Results

Compared to normal group, the mRNA levels of survivin of ectopic endometrium and eutopic endometrium were significantly increased, the mRNA levels of bcl-2, cox-2 were significantly increased too. The total mRNA levels of survivin, bcl-2 and cox-2 were positively correlated with endometriosis, and the correlations of three were obvious.

Conclusion

Abnormal up-regulation of Survivin, Bcl-2 and Cox-2 in the endometriosis patients might be one of molecular biologic mechanisms for ecotopic implantation and development of endometrium. Furthermore, three genes were highly associated to the endometriosis progress.

图1 总RNA电泳图谱
图2 预试验内对照电泳图
图3 Survivin电泳图谱
图4 Cox-2电泳图谱
图5 Bcl-2电泳图谱
图6 总RNA电泳图谱(18s,28s)
图7 Survivin与Cox-2相关散点图
图8 Survivin与Bcl-2相关散点图
图9 Cox-2与Bcl-2相关散点图
1 Giudice LC, Tazuke SI, Swiersz L. Status of current research on endometriosis. J Reprod Med, 1998,43(Suppl 3):252-262.
2 Selam B, Arici A. Implantation defect in endometriosis: Endometrium or peritoneal fluid. J Reprod Fertil Suppl,2000,55:121-128.
3 Suganuma N, Harada M, Furuhashi M, et al. Apoptosis in human endometrial and endometriotic tissues. Horm Res,1997,48(Suppl 3):42-47.
4 Kennedy S. Genetics of endometriosis:A review of the positional cloning approaches. Semin Reprod Med,2003,21:111-118.
5 Lang JH. Cornerstone of study on endometriosis. Chin J Obstet Gynecol, 2005,40(1):3-4.[郎景和. 子宫内膜异位症研究的新里程. 中华妇产科杂志,2005, 40(1):3-4.]
6 LaCasse EC, Baird S, Korneluk RG, et al. The inhibitors of apoptosis (IAPS) and their emerging role in cancer. Oncogene,1998, 17(25):3247-3259.
7 Sung BJ, Cho YS, Kim HJ, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7.Biochemistry, 2001,40(4): 1117-1126.
8 Suzuki A, Ito T, Kawano H,et al.Survivin initiates procaspase-3/p21 complex formation as a result of interaction with CDK4 to resist fas-mediated cell death.Oncogene,2000,19(10):1346-1355.
9 Wheatley SP, McNeish IA. A protein with dual roles in mitosis and apoptosis. INT Rev Cytol, 2005,247(1):34-88.
10 Parenti A,Leo G,Porzionato A, et al. Expression of survivin, p53, and caspase 3 in Barrett's esophagus carcinogenesis. Hum Pathol, 2006, 37(1):16-22.
11 Papapetropoulos A,Fulton D,Mubboubi K, et al. Angiopoietin-1 inhibits endothelial cell. J Biol Chem, 2002,275(13):9102.
12 Oconnor DS, Schechner JS, Adida C, et al. Control of apoptosis during angiogenesis by surviving express in endothelial cell. Am J Pathol,2000,156(2):393.
13 Letsas KP, Frangou LM, Skyrlas A, et al. Transcription factor-mediated proliferation and apoptosis in benign and malignant thyroid lesions. Pathol Int, 2005,55(11): 694-702.
14 Gong FL, editor. Apoptosis and immunity. Med Immunol, Beijing:Science Publishing House,2004, 6:251-263.[龚非力主编. 医学免疫学. 北京:科学出版社,2004,251-263.]
15 Chishima F, Hayakawa S, Sugita K,et al.Increased expression of cycloosygenase-2 in local lesions of endometriosis patients.Am J Reprod Immunol,2002,48(1):50-56.
16 Ota H, Igarashi S, Sasaki M, et al. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod, 2001, 16(3):561-566.
17 Lin MT, Lee RC, Yang PC,et al. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adrnocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem, 2001,276:48997-49002.
18 Lang JH.Summary of the eighth international congresses on endometriosis. Chin J Obstet Gynecol,2002,37:638-4-640.[郎景和,冷金花,赵栋等. 第八届国际子宫内膜异位症学术会议纪要. 中华妇产科杂志,2002,37(1):638-640.]
[1] 罗丹, 孔为民, 陈姝宁, 赵小玲, 谢云凯. 子宫内膜异位症患者在位及异位内膜上皮细胞-间充质转化相关生物标志物的变化[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 530-539.
[2] 陈雨婷, 杨烨, 谢奇君, 凌秀凤. 女性不孕不育相关疾病患者的生殖道微生物组成异常研究现状[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(05): 615-620.
[3] 黄品秀, 曾定元. 孕酮受体在人子宫内膜基质细胞蜕膜化过程中的作用机制研究现状[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(02): 245-248.
[4] 杜娟, 宋波, 颜晓明, 牛佳鸣, 林元龙, 陈晓红, 李锦, 梁晗, 张铮, 李宇欧, 王福祥, 邵冰. 外周血单个核细胞内人类免疫缺陷病毒DNA和RNA定量对病毒转录活性的区分[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(03): 165-171.
[5] 孙睿, 梁辉, 张颖, 邓琼, 胡七一, 张圣平, 张建文, 王铸. 基因芯片分析孤儿核受体NURR1上调表达对前列腺癌LNCaP细胞基因表达谱的影响[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(01): 81-85.
[6] 杨泽成, 史常赛, 陈佳乐, 李金龙. 腹壁子宫内膜异位症相关性透明细胞癌一例及文献回顾[J]. 中华疝和腹壁外科杂志(电子版), 2022, 16(05): 595-599.
[7] 陈俊杰, 郭浩然, 施波, 陈国梁, 邰清亮, 侍新宇, 姚慧慧, 米秀伟, 王索, 孙金兵, 周迪远, 顾闻, 何宋兵. 基于TCGA和GEO数据挖掘分析NAT1在结肠癌中的表达及预后意义[J]. 中华结直肠疾病电子杂志, 2022, 11(05): 399-408.
[8] 许航, 崔宇韬, 任广凯, 刘贺, 王雁冰, 彭传刚, 吴丹凯. 骨质疏松症关键基因的筛选及生物信息学分析[J]. 中华老年骨科与康复电子杂志, 2023, 09(01): 18-22.
[9] 孙超, 朱滢, 柴海娜, 孙欣欣. 直肠子宫内膜异位症10例临床分析[J]. 中华消化病与影像杂志(电子版), 2022, 12(04): 246-248.
[10] 王飞飞, 王光林, 孟泽松, 李保坤, 曹龙飞, 张娟, 周超熙, 丁源一, 王贵英. 敲低IMPDH1对结肠癌SW480、HT29细胞生物功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(08): 884-890.
[11] 王丁然, 迟洪滨. 自身免疫甲状腺炎对子宫内膜异位症患者胚胎移植结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(06): 682-688.
[12] 王宁, 吴慢莉, 杨东霞. 代谢组学生物标志物:子宫内膜异位症诊疗的新靶点[J]. 中华临床医师杂志(电子版), 2022, 16(12): 1280-1283.
[13] 兰素伟, 王春辉, 常丽凤, 王杏茶, 翟明晶, 李阳. 血清miRNA-10b和miRNA-34a在子宫内膜异位症患者中的表达及与术后复发关系研究[J]. 中华临床医师杂志(电子版), 2022, 16(08): 759-763.
[14] 汪泉, 周英妹, 何颖. p27、cyclin-E在子宫内膜异位症中的表达及其临床意义[J]. 中华临床医师杂志(电子版), 2022, 16(06): 546-552.
[15] 谢玉莹, 德丽娜尔·乌尔肯别克, 毛新敏, 张莉. 强化心理干预护理模式对子宫内膜异位症手术患者负性情绪的改善效果研究[J]. 中华临床医师杂志(电子版), 2022, 16(05): 457-462.
阅读次数
全文


摘要